Patterns of breast cancer mortality trends in Europe

Breast

Volumn 22, Issue 3, 2013, Pages 244-253

  Amaro, Joana ^a,b   Severo, Milton ^a,b   Vilela, Sofia ^a   Fonseca, Sérgio ^a   Fontes, Filipa ^a   La Vecchia, Carlo ^c,d   Lunet, Nuno ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast neoplasms; Cluster analysis; Early detection of cancer; Mortality

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; ECONOMIC DEVELOPMENT; EUROPE; GEOGRAPHIC DISTRIBUTION; GROSS NATIONAL PRODUCT; HEALTH CARE QUALITY; HUMAN; PRIORITY JOURNAL; STANDARDIZED MORTALITY RATIO; TREND STUDY;

EID: 84877112612     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.02.007     Document Type: Article

References (76)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer Journal of Clinicians 2011 , 61(2):69-90.
2. Bosetti C., Bertuccio P., Levi F., Chatenoud L., Negri E., La Vecchia C. The decline in breast cancer mortality in Europe: an update (to 2009). Breast 2012, 21(1):77-82.
3. Sant M., Francisci S., Capocaccia R., Verdecchia A., Allemani C., Berrino F. Time trends of breast cancer survival in Europe in relation to incidence and mortality. International Journal of Cancer 2006, 119(10):2417-2422.
4. Hulka B.S., Moorman P.G. Breast cancer: hormones and other risk factors. Maturitas 2008, 61(1-2):203-213. [discussion 13].
5. Key T.J., Verkasalo P.K., Banks E. Epidemiology of breast cancer. The Lancet Oncology 2001, 2(3):133-140.
6. Althuis M.D., Dozier J.M., Anderson W.F., Devesa S.S., Brinton L.A. Global trends in breast cancer incidence and mortality 1973-1997. International Journal of Epidemiology 2005, 34(2):405-412.
7. Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. The New England Journal of Medicine 2005, 353(17):1784-1792.
8. Sukel M.P., van de Poll-Franse L.V., Nieuwenhuijzen G.A., Vreugdenhil G., Herings R.M., Coebergh J.W., et al. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. European Journal of Cancer 2008, 44(Issue 13):1846-1854.
9. Julien J.P., Bijker N., Fentiman I.S., Peterse J.L., Delledonne V., Rouanet P., et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000, 355(9203):528-533.
10. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998, 351(9114):1451-1467.
11. Cole B.F., Gelber R.D., Gelber S., Coates A.S., Goldhirsch A. Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet 2001, 358(9278):277-286.
12. Benach J., Yasui Y., Borrell C., Rosa E., Pasarín M.I., Benach N., et al. Examining geographical patterns of mortality - the Atlas of mortality in small areas in Spain (1987-1995). European Journal of Public Health 2003, 13(Nr. 2):115-223.
13. Fukuda Y., Umezaki M., Nakamura K., Takano T. Variations in societal characteristics of spatial disease clusters: examples of colon, lung and breast cancer in Japan. International Journal of Health Geographics 2005, 4:16.
14. Ed Hsu C., Jacobson H., Soto Mas F. Evaluating the disparity of female breast cancer mortality among racial groups - a spatiotemporal analysis. International Journal of Health Geographics 2004, 3(4).
15. Tian N., Gaines Wilson J., Benjamin Zhan F. Female breast cancer mortality clusters within racial groups in the United States. Health & Place 2010, 16(Issue 2):209-218.
16. World Health Organization Statistical Information System. WHO mortality database. Available from: . [cited accessed January 2012]. http://www.who.int/whosis/mort/download/en/index.html.
17. United Nations. World Population Prospects: The 2010 revision - special aggregates. Available from: [cited 30.05.2012]. http://esa.un.org/unpd/wpp/index.htm.
18. Breslow N.E., Day N.E. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies 1987, 82. IARC scientific publications, [1-406].
19. Pinheiro J.C., Bates D.M. Mixed-effects models in S and S-plus 2000, Springer Verlag.
20. Fraley C., Raftery A.E. Model-based clustering, discriminant analysis, and density estimation. Journal of the American Statistical Association 2002, 97(458):611-631.
21. Fraley C., Raftery A.E. Bayesian regularization for normal mixture estimation and model-based clustering. Journal of Classification 2007, 24(2):155-181.
22. Schwarz G. Estimating dimension of a model. Annals of Statistics 1978, 6(2):461-464.
23. Pinheiro J., Bates D., DebRoy S. Linear and nonlinear mixed effects models. R Package Version 2007, 3:57.
24. Fraley C., Raftery A.E., Murphy B., Scrucca L. Mclust version 4 for R: normal mixture modeling and model-based clustering, classification, and density estimation 2012, Technical Report no. 597, Department of Statistics, University of Washington, Washington.
25. The World Bank. World development indicators. Available from: [cited 31.01.2012]. http://data.worldbank.org/indicator/NY.GDP.PCAP.CD.
26. Ferlay J., Parkin D.M., Curado M.P., Bray F., Edwards B., Shin H.R., et al. Cancer incidence in five Continents. Volumes I to IX: IARC CancerBase No. 9 2010, [Internet], International Agency for Research on Cancer, Lyon, France, Available from:, [cited; Available from:]. http://ci5.iarc.fr.
27. Perry N., Broeders M., de Wolf C., Tornberg S., Holland R., von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition-summary document. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO 2008, 19(4):614-622.
28. Joinpoint regression program. Version 3.5 April, Statistical Methodology and Applications Branch and Data Modeling Branch, Surveillance Research Program National Cancer Institute.
29. Schopper D., de Wolf C. Breast cancer screening by mammography: International evidence and the situation in Switzerland 2007, CdW, Bern, June 2007.
30. Information Services Division of Scotland. Scottish breast screening programme. Available from: [cited 24.09.2012]. http://www.isdscotland.org/Health-Topics/Cancer/Breast-Screening/.
31. Barchielli A., Federico M., De Lisi V., Bucchi L., Ferretti S., Paci E., et al. In situ breast cancer: incidence trend and organised screening programmes in Italy. European Journal of Cancer 2005, 41(7):1045-1050.
32. Botha J.L., Bray F., Sankila R., Parkin D.M. Breast cancer incidence and mortality trends in 16 European countries. European Journal of Cancer 2003, 39(Issue 12).
33. Independent UK Panel on Breast Cancer Screening The benefits and harms of breast cancer screening: an independent review. The Lancet 2012.
34. La Vecchia C., Negri E., Bruzzi P., Franceschi S., Bucchi L., Parazzini F. The impact of mammography on breast cancer detection. Annals of oncology. Official Journal of the European Society for Medical Oncology/ESMO 1993, 4(1):41-44.
35. Kalager M., Adami H.O., Bretthauer M., Tamimi R.M. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Annals of Internal Medicine 2012, 156(7):491-499.
36. Zahl P.H., Maehlen J., Welch H.G. The natural history of invasive breast cancers detected by screening mammography. Archives of Internal Medicine 2008, 168(21):2311-2316.
37. Parkin M., Fernández L. Use of statistics to assess the global burden of breast cancer. The Breast Journal 2006, 12(Suppl. 1):S70-S80.
38. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2006, 24(14):2137-2150.
39. Kalager M., Zelen M., Langmark F., Adami H.O. Effect of screening mammography on breast-cancer mortality in Norway. The New England Journal of Medicine 2010, 363(13):1203-1210.
40. Shapiro S. Screening: assessment of current studies. Cancer 1994, 74(1):231-238.
41. Holland W., Stewart S., Masseria C. Policy brief: screening in Europe 2006, World Health Organization, Copenhagen.
42. Boncz I., Sebestyen A., Pinter I., Battyany I., Ember I. The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities. Journal of Medical Screening 2008, 15(1):14-17.
43. Majek O., Danes J., Skovajsova M., Bartonkova H., Buresova L., Klimes D., et al. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC Public Health 2011, 11:288.
44. Zwahlen M., Bopp M., Probst-Hensch N.M. Mammography screening in Switzerland: limited evidence from limited data. Swiss Medical Weekly 2004, 134(21-22):295-306.
45. Palencia L., Espelt A., Rodriguez-Sanz M., Puigpinos R., Pons-Vigues M., Pasarin M.I., et al. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. International Journal of Epidemiology 2010, 39(3):757-765.
46. Bulliard J.L., Ducros C., Jemelin C., Arzel B., Fioretta G., Levi F. Effectiveness of organised versus opportunistic mammography screening. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO 2009, 20(7):1199-1202.
47. IARC Working Group on the Evaluation of Cancer-Prevention Strategies IARC handbooks of cancer prevention, breast cancer screening 2002, IARC Press, Lyon.
48. Jatoi I., Miller A.B. Why is breast-cancer mortality declining?. The Lancet Oncology 2003, 4.
49. Geran L., Tully P., Wood P., Thomas B. Comparability of ICD-10 and ICD-9 for mortality statistics in Canada 2005, Minister of Industry, Ottawa.
50. Klebba A.J., Scott J.H. Estimates of selected comparability ratios based on dual coding of 1976 death certificates by the eighth and ninth revisions of the international Classification of diseases 1980, National Center for Health Statistics, Maryland.
51. Efron B., Tibshirani R. Improvements on cross-validation: the .632+ bootstrap method. Journal of the American Statistical Association 1997, 92:548-560.
52. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174.
53. Cancer incidence in five continents 2008, Vol. IX. IARC Scientific Publications, 160 pp. 1-837.
54. Olsen A.H., Jensen A., Njor S.H., Villadsen E., Schwartz W., Vejborg I., et al. Breast cancer incidence after the start of mammography screening in Denmark. British Journal of Cancer 2003, 88(3):362-365.
55. von Euler-Chelpin M. Breast cancer incidence and use of hormone therapy in Denmark 1978-2007. Cancer Causes and Control 2011, 22(Nr. 2):181-187.
56. Von Karsa L., Antilla A., Anttila A., Ronco G., Ponti A., Malila N., Arbyn M., et al. Cancer screening in the European Union, report on the implementation of the Council Recommendation on cancer Screening 2008, First Report, European Comission, Luxembourg.
57. National Cancer Screening Service Breast check-The National breast screening programme 2011, Programme report 2010/11. Ireland.
58. National cancer screening service 2012, Available from:, [cited 12.10.12]. http://www.cancerscreening.ie/screening.html.
59. Bastos J., Peleteiro B., Gouveia J., Coleman M.P., Lunet N. The state of the art of cancer control in 30 European countries in 2008. International Journal of Cancer 2010, 126(11):2700-2715.
60. van den Akker-van Marle E., de Koning H., Boer R., van der Maas P. Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: comparison with the United Kingdom. Journal of Medical Screening 1999, 6:30-34.
61. Advisory Committee on Breast Cancer Screening Screening for breast cancer in England: past and future. Journal of Medical Screening 2006, 13(2):59-61.
62. Wanner P., Raymond L., Bouchardy C. Geographical disparities in self reported use of mammography and breast self-examination according to the Swiss Health Survey. Annals of Oncology 2001, 12:573-575.
63. Frede T.E. Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary?. European Journal of Radiology 2005, 55(1):130-138.
64. Oberaigner W., Buchberger W., Frede T., Knapp R., Marth C., Siebert U. Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening. BMC Public Health 2010, 10:86.
65. Biesheuvel C., Weigel S., Heindel W. Mammography screening: evidence, history and current practice in Germany and other European countries. Breast Care (Basel) 2011, 6(2):104-109.
66. Boncz I., Sebestyen A., Dobrossy L., Pentek Z., Budai A., Kovacs A., et al. The organisation and results of first screening round of the Hungarian nationwide organised breast cancer screening programme. Annals of oncology. Official Journal of the European Society for Medical Oncology/ESMO 2007, 18(4):795-799.
67. Giorgi D., Giordano L., Ventura L., Frigerio A., Paci E., Zappa M. Mammography screening in Italy: 2004 survey and 2005 preliminary data. Epidemiologia & Prevenzione 2007, 31(2-3 Suppl. 2):7-20.
68. Kalager M., Haldorsen T., Bretthauer M., Hoff G., Thoresen S.O., Adami H.O. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Research 2009, 11(4):R44.
69. Luengo-Matos S., Polo-Santos M., Saz-Parkinson Z. Mammography use and factors associated with its use after the introduction of breast cancer screening programmes in Spain. European Journal of Cancer Prevention 2006, 15:242-248.
70. World Health Organization Strengthening cancer prevention and screening in Belarus 2012, [cited 12/10/2012]; Available from:. http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/cancer/news/news/2011/3/strengthening-cancer-prevention-and-screening-in-belarus.
71. Ciraj-Bjelac O., Faj D., Stimac D., Kosutic D., Arandjic D., Brkic H. Good reasons to implement quality assurance in nationwide breast cancer screening programs in Croatia and Serbia: results from a pilot study. European Journal of Radiology 2011, 78(1):122-128.
72. Ljubicic N., Ivanda T., Strnad M., Brkljacic B. The Croatian national breast cancer screening program-"mamma". The Breast Journal 2011, 17(1):106-108.
73. Institute for Statistical and Epidemiological Cancer Research. Finnish Cancer Registry. Available from: [cited 10.10.2012]. http://www.cancer.fi/syoparekisteri/en/.
74. Wait S.H., Allemand H.M. The French breast cancer screening programme - epidemiological and economic results of the first round of screening. European Journal of Public Health 1996, 16(No. 1):43-48.
75. Simou E., Tsimitselis D., Tsopanlioti M., Anastasakis I., Papatheodorou D., Kourlaba G., et al. Early evaluation of an organised mammography screening program in Greece 2004-2009. Cancer Epidemiology 2011, 35(4):375-380.
76. Olsson S., Andersson I., Karlberg I., Bjurstam N., Frodis E., Hakansson S. Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. Journal of Medical Screening 2000, 7(1):14-18.